Scientific Resources

Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.

Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.

Clinical Trial Showcase at ASH 2024 – ALPHA3
December 18, 2024 | Presentation
Escalating Doses of AZD0486, a Novel CD19xCD3 T-cell Engager, Result in High Complete Remissions with Rapid Clearance of Minimal Residual Disease in Patients with Relapsed/Refractory Follicular Lymphoma
December 17, 2024 | Presentation
Advancing precision medicine in lymphoma with ctDNA-MRD – presentation by Dr. Mark Roschewski (NCI/NIH)
December 17, 2024 | Video
Mosunetuzumab Plus Polatuzumab Vedotin Induces Early Complete Responses in Previously Untreated High Tumor Burden Follicular Lymphoma
December 13, 2024 | Poster
Using Circulating Tumor DNA to Spare Patients with Diffuse Large B-cell Lymphoma Unnecessary Treatment and Cost: a Model-based Analysis
December 13, 2024 | Poster
Circulating tumor DNA clearance by neoadjuvant chemotherapy or breast surgery detected using an ultra-sensitive ctDNA MRD assay in early breast cancer
December 13, 2024 | Poster